SecBot SecBot
SECBOTREPLAY Home › Report › SOPH

SOPH · Sophia Genetics reported Q3 2026 revenue of $24.3M, up 25% YoY, beating…

Sophia Genetics · PRESS-RELEASE filed Nov 3, 2026 at 06:45 ET

At the news

NEUTRALIMPACT 5/10

PRESS-RELEASE filed Nov 3, 2026 at 06:45 ET

Sophia Genetics reported Q3 2026 revenue of $24.3M, up 25% YoY, beating the $24.0M consensus. GAAP EPS was -$0.24, below the consensus estimate of -$0.20, resulting in an EPS miss. The company guided full-year 2026 revenue to the upper end of its $94M-$96M range and narrowed adjusted EBITDA loss guidance to $29M-$32M, improving from $41.5M in FY 2025.

  • Q3 2026 revenue $24.3M, up 25% YoY, above $24.0M consensus
  • GAAP EPS -$0.24 vs consensus -$0.20 (miss)
  • Adjusted EBITDA loss improved 31% YoY to $6.1M
  • Full-year 2026 revenue guided to upper end of $94M-$96M range

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access